T 0432/24 (C-Met modulator / EXELIXIS) of 22.01.2026
- European Case Law Identifier
- ECLI:EP:BA:2026:T043224.20260122
- Date of decision
- 22 January 2026
- Case number
- T 0432/24
- Online on
- 19 March 2026
- Petition for review of
- -
- Application number
- 11740764.3
- IPC class
- A61K 31/47A61K 9/20A61K 9/28
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- C-MET MODULATOR PHARMACEUTICAL COMPOSITIONS
- Applicant name
- Exelixis, Inc.
- Opponent name
- STADA Arzneimittel AG
Teva Pharmaceutical Industries Ltd
Generics (U.K.) Limited - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 12(3)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Admittance of late-filed items of evidence - yes
Amendments - allowable (yes)
Statement of grounds of appeal - reasons set out clearly and concisely (no)
Sufficiency of disclosure - (yes)
Inventive step - (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeals are dismissed.